Endocrine Complications of Childhood Hematopoietic Stem-Cell Transplantation

Pediatric Hematopoietic Stem Cell Transplantation

Volumn , Issue , 2006, Pages 287-298

  Chemaitilly, Wassim ^a   Boulad, Farid ^b   Sklar, Charles ^b  

^a Weill Cornell Medical Library   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954541354     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780849358807-18     Document Type: Chapter

References (73)

1. Boulad F, Sands S, Sklar C. Late complications after BMT in children and adolescents. Curr Probl Pediatr 1998; 28:277-297.
2. Cohen A, Rovelli A, Bakker B, et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the working party for late effects-EBMT. Blood 1999; 93:4109-4115.
3. Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996; 129:544-550.
4. Frisk P, Arvidson J, Gustafsson J, Lonnerholm G. Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 2004; 33:205-210.
5. Sklar C, Boulad F, Small T, Kernan N. Endocrine complications of pediatric stem cell transplantation. Front Biosci 2001; 6:17-22.
6. Sanders JE, Pritchard S, Mahoney P, et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68:1129-1135.
7. Giorgiani G, Bozzola M, Locatelli F, et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86:825-831.
8. Adan L, de Lanversin M-L, Thalassinos C, Souberbielle JC, Fischer A, Brauner R. Growth after bone marrow transplantation in young children conditioned with chemotherapy alone. Bone Marrow Transplant 1997; 19:253-256.
9. Afify A, Shaw PJ, Clavano-Harding A, Cowell CT. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000; 25:1087-1092.
10. Sanders JE. Growth and development after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. Boston: Blackwell Scientific Publications, 1994:527-537.
11. Bakker B, Oostdijk W, Bresters D, Walenkamp MJE, Vossen JM, Wit JM. Disturbances of growth and endocrine function after busulfan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004; 33:1049-1056.
12. De Sanctis V. Growth and puberty and its management in thalassemia. Horm Res 2002; 58:72-79.
13. Bushhouse S, Ramsay NKC, Pescovitz OH, Kim T, Robison LL. Growth in children following irradiation for bone marrow transplantation. Am J Pediatr Hem/Oncol 1989; 11:134-140.
14. Couto-Silva AC, Trivin C, Esperou H, Michon J, Fischer A, Brauner R. Changes in height, weight and plasma leptin after bone marrow transplantation. Bone Marrow Transplant 2000; 26:1205-1210.
15. Brauner R, Fontoura M, Zucker JM, et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993; 68:458-463.
16. Thomas BC, Stanhope R, Plowman PN, Leiper AD. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 1993; 152:888-892.
17. Wither HR. Biologic basis for altered fractionation schemes. Cancer 1985; 55:2086-2095.
18. Yahalom J, Fuks ZY. Strategies for the use of total body irradiation as a systemic therapy in leukemia and lymphoma. In: Armitage JO, Antman KH, eds. High Dose Chemotherapy. Baltimore: Williams and Wilkins, 1992:61-83.
19. Holm K, Nysom K, Rasmussen MH, et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant 1996; 18:163-170.
20. Brauner R, Adan L, Souberbielle JC, et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997; 130:785-792.
21. Brennan BMD, Shalet MS. Endocrine late effects after bone marrow transplantation. Br J Haematol 2002; 118:56-66.
22. Papadimitrou A, Uruena M, Stanhope R, Leiper AD. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child 1991; 66:689-692.
23. Ogilvy-Stuart AL, Clark DJ, Wallace WHB, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992; 67:1107-1110.
24. Huma Z, Boulad F, Black P, Heller G, Sklar C. Growth in children after bone marrow transplantation for acute leukemia. Blood 1995; 86:819-824.
25. Wingard JR, Plotnick LP, Freemer CS, et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992; 79:1068-1073.
26. Bozzola M, Giorgiani G, Locatelli F, et al. Growth in children after bone marrow transplantation. Horm Res 1993; 39:122-126.
27. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997; 130:210-216.
28. Reiter EO, Rosenfeld RG. Normal and abnormal growth. In: Larsen PR, Kronenberg HM, Melmed S et al. eds. Williams Textbook of Endocrinology. Philadelphia: WB Saunders, 2003:1003-1114.
29. Lissett CA, Saleem S, Rahim A, Brennan BMD, Shalet SM. The impact of irradiation on GH responsiveness to provocative agents is stimulus dependent: results in 161 individuals with radiation damage to the somatotropic axis. J Clin Endocrinol Metab 2001; 86:663-668.
30. Darzy KH, Aimaretti G, Wieringa G, Rao Gattamaneni H, Chigo E, Shalet SM. The usefulness of the combined growth hormone (GH) releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 2003; 88:95-102.
31. Sklar C, Sarafoglou K, Whittam E. Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol 1993; 129:511-515.
32. Fletcher BD, Crom DB, Krance RA, Kun L. Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. Radiology 1994; 191:231-235.
33. Sklar CA, Mertens AC, Mitsby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 2002; 87:3136-3141.
34. Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR. Final adult height of patients who received hematopoietic cell transpantation in childhood. Blood 2005; 105:1348-1354.
35. Kauppila M, Koskinen P, Irjala K, Remes K, Viikari J. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults. Bone Marrow Transplant 1998; 22:331-337.
36. Littley MD, Shalet SM, Morgenstern GR, Deaken DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. QJM 1991; 78:265-274.
37. Rose SR, Lustig RH, Pituksheewanont P, et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999; 84:4472-4479.
38. Sanders JE. The Seattle marrow transplant team. The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 1991; 28:244-249.
39. Thomas BC, Stanhope R, Plowman PN, Leiper AD. Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol 1993; 128:508-512.
40. Boulad F, Bromley M, Black P, et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15:71-76.
41. Sklar CA, Kim TH, Ramsay NKC. Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 1982; 73:688-694.
42. Michel G, Socie G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation—a report from the societe; francaise de greffe de moelle. J Clin Oncol 1997; 15:2238-2246.
43. Slatter MA, Gennery AR, Cheetham TD, et al. Thyroid dysfunction after bone marrow transplantation for primary immune deficiency without the use of total body irradiation. Bone Marrow Transplant 2004; 33:949-953.
44. Karthaus M, Gabrysiak T, Brabant G, et al. Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells. Bone Marrow Transplant 1997; 20:697-699.
45. Holland FJ, McConnon JK, Volpe R, Saunders EF. Concordant Graves’ disease after bone marrow transplantation: implications for pathogenesis. J Clin Endocrinol Metab 1991; 72:837-840.
46. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Res 1995; 141:259-277.
47. Tucker MA, Jones PH, Boice JD, Jr., et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991; 51:2885-2888.
48. Acharya S, Sarafoglou K, LaQuaglia M, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood and adolescence. Cancer 2003; 97:2397-2403.
49. Cohen A, Rovelli A, van Lint MT, et al. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 2001; 28:1125-1128.
50. Uderzo C, van Lint MT, Rovelli A, et al. Papillary thyroid carcinoma after total body irradiation. Arch Dis Child 1994; 71:256-258.
51. Sanders JE. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant 2004; 8:39-50.
52. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87:3045-3052.
53. Anserini P, Chiodi S, Costa M, Conte N, Copello F, Bacigalupo A. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant 2002; 30:447-451.
54. Grigg AP, McLachlan R, Zajac J, Szer J. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow Transplant 2000; 26:1089-1095.
55. Sklar CA, Robison LL, Nesbit ME, et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the children’s cancer study group. J Clin Oncol 1990; 8:1981-1987.
56. Sklar CA, Kim TH, Ramsay NKC. Testicular function following bone marrow transplantation performed during or after puberty. Cancer 1984; 53:1498-1501.
57. Sanders JE, Buckner CD, Amos D, et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6:813-818.
58. Byrne J, Fears TR, Gail MH, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166:788-793.
59. Mertens AC, Ramsay NKC, Kouris S, Neglia JP. Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant 1998; 22:345-350.
60. Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999; 80:452-454.
61. Holm K, Nysom K, Brocks V, Hertz H, Jacobsen N, Muller J. Ultrasound B-mode changes in the uterus and ovaries and doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant 1999; 23:259-263.
62. Bath LE, Critchley HOD, Chambers SE, Anderson RA, Kelnar CJH, Wallace WHB. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gyneacol 1999; 106:1265-1272.
63. Aisenberg J, Hsieh K, Kalaitzoglou G, et al. Bone mineral density (BMD) in long-term survivors of childhood cancer. J Pediatr Hematol Oncol 1998; 20:241-245.
64. Bhatia S, Ramsay NKC, Weisdorf D, Griffiths H, Robison LL. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998; 22:87-90.
65. Nysom K, Holm K, Michaelsen KF, et al. Bone mass after allogeneic bone marrow transplantation for childhood leukaemia or lymphoma. Bone Marrow Transplant 2000; 25:191-196.
66. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 2003; 14:617-630.
67. Stern JM, Chesnut CH, III, Bruemmer B, et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 1996; 17:395-400.
68. Gilsanz V, Carlson ME, Roe TF, Ortega JA. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990; 117:238-244.
69. Lee WY, Cho SW, Oh ES, et al. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 2002; 87:329-335.
70. Lee WY, Kang MI, Oh ES, et al. The role of cytokines in the changes in bone turnover following bone marrow transplantation. Osteoporos Int 2002; 13:62-68.
71. Smedmyr B, Wilbell L, Simonsson B, Oberg G. Impaired glucose tolerance after autologous bone marrow transplantation. Bone Marrow Transplant 1990; 6:89-92.
72. Lorini R, Cortona L, Scaramuzza A, et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995; 15:873-877.
73. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone marrow transplantation in childhood. Lancet 2000; 356:993-997.